供应商集中及依赖主要供应商

港股IPO招股书披露先例 · 541 家公司,561 项

供应商集中及依赖主要供应商,指申请人向最大或前五大供应商采购占比较高,或关键原料及服务依赖单一或少数来源。招股书一般在概要、风险因素、业务及财务资料章节披露各期前五大及最大供应商的采购占比、供应商性质及是否涉及关联方,并解释集中度成因;申请人通常以长期合作关系、多元采购及备选供应商、供应商管理制度,以及董事确认供应稳定且无重大纠纷等方式回应依赖风险。

2026-06-18Application Proof
广州知易生物科技股份有限公司Guangzhou Zhiyi Biotechnology Co., Ltd.

关键培养基仅从少数国际供应商采购

For one of our key culture media products, we currently source from a limited number of international suppliers; however, we have completed process validation studies for alternative suppliers and intend to maintain at least three qualified supplier options upon NDA/BLA approval.

Business · 第 194 页

Moreover, we generally maintain approximately three months of inventory for our principal raw materials.

Business · 第 194 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-18Prospectus
礼邦医药(江苏)股份有限公司Alebund Pharmaceuticals (Jiangsu) Limited09637.HK

前五大供应商采购占比及供应商集中

For the years ended December 31, 2024 and 2025, purchases from our five largest suppliers in aggregate accounted for 57.0% and 46.4% of our total purchases, respectively.

Business · 第 198 页

Our purchases from our largest supplier in each year during the Track Record Period amounted to RMB110.5 million and RMB31.4 million, representing 21.9% and 11.2% of our total purchases for the respective year.

Business · 第 198 页

Although we primarily use a limited number of suppliers, there are alternate suppliers available for our needs for services, equipment and consumables.

Business · 第 198 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-17Application Proof
北京融信数联科技股份有限公司Beijing Rongxin Datainfo Science and Technology Co., Ltd.

前五大供应商采购占比升至56.2%

For FY2023, FY2024 and FY2025, the percentage of our total purchases from our top supplier for each year during the Track Record Period amounted to approximately 8.9%, 11.8% and 18.9% respectively, while the percentage of our total purchases from our top five suppliers for each year during the Track Record Period combined amounted to approximately 31.7%, 37.5% and 56.2%, respectively.

Business · 第 141 页

We also collaborate with multiple suppliers to ensure a stable supply.

Business · 第 146 页

We have not committed to any minimum purchase amount with any of our suppliers.

Business · 第 141 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-17Application Proof
江苏博迁新材料股份有限公司Jiangsu Boqian New Materials Stock Co., Ltd.

前五大供应商采购占比约73%至77%

Purchases from our five largest suppliers for the years ended December 31, 2023, 2024 and 2025 amounted to RMB283.9 million, RMB317.2 million and RMB405.3 million, accounting for 72.9%, 77.3% and 74.6%, respectively, of our total purchase amount for the respective periods.

Business · 第 120 页

According to Frost & Sullivan, the relatively high concentration of five largest suppliers during the Track Record Period aligns with industry norms in China.

Business · 第 122 页

We apply a rigorous evaluation process, including initial assessment, sample testing and small-batch trials, and maintain a list of qualified backup suppliers to mitigate single-source disruption risks.

Business · 第 122 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-17Prospectus
广东领益智造股份有限公司LINGYI iTECH (GUANGDONG) COMPANY01688.HK

前五大供应商采购占比升至近三成

During the Track Record Period, our aggregate purchase from the five largest suppliers in each year during the Track Record Period was RMB3,567.8 million, RMB8,702.8 million and RMB9,404.3 million, respectively, accounting for 16.5%, 31.0% and 29.8% of our total purchase, respectively, in 2023, 2024 and 2025.

Summary · 第 7 页

The increase in supplier concentration during the Track Record Period was mainly driven by the growth in procurement volume associated with the expansion of our imaging and display business.

Business · 第 167 页

To ensure the stability of our supply chain and mitigate the risk of supply disruptions, we maintain multiple qualified suppliers for each major material or product category, except where suppliers are designated by customers.

Business · 第 167 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-17Prospectus
北京中科闻歌科技股份有限公司Beijing Zhongke WengeAI Science and Technology Co., Ltd.01956.HK

前五大供应商采购占比约四分之一

Purchase costs from our largest supplier in each year or period during the Track Record Period accounted for 7.1%, 8.0% and 8.0%, respectively, of our total purchases for the respective year or period.

Summary · 第 9 页

Purchase costs from our five largest suppliers in each year or period during the Track Record Period accounted for 25.4%, 26.8%, and 24.0%, respectively, of our total purchases for the respective year or period.

Business · 第 184 页

As of the Latest Practicable Date, none of our Directors, their associates or any of our shareholders (who or which to the knowledge of the Directors owned more than 5% of our issued share capital) had any interest in any of our five largest suppliers.

Business · 第 188 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-17Prospectus

前五大供应商采购占比逾九成

Purchases from our five largest suppliers in each year of the Track Record Period accounted for 92.4%, 92.3% and 91.0% of our total purchases, respectively.

Business · 第 151 页

As we source a significant portion of wafers and packaging and testing services from our major suppliers, if our relationships with our major suppliers are terminated, interrupted, or modified in any way adverse to us, there may be material interruptions to our operations and business.

Business · 第 153 页

We dynamically allocate order volumes among our major suppliers to avoid over-reliance on any single entity.

Business · 第 153 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-16Application Proof
上海君赛生物股份有限公司Shanghai Juncell Therapeutics Co., Ltd.

前五大供应商采购占比2024年46.5%、2025年37.9%

In 2024 and 2025, our purchases from our five largest suppliers in each year in aggregate amounted to RMB47.3 million and RMB56.3 million, representing 46.5% and 37.9% of our total corresponding purchases in such year, respectively, and our purchases from the largest supplier in each year accounted for 27.3% and 25.1% of our total corresponding purchases, respectively.

Business · 第 188 页

In addition, we believe that adequate alternative sources exist for these services and supplies, and we have developed alternative sourcing strategies based on supply continuity risk assessments.

Business · 第 187 页

All of our five largest suppliers in each year during the Track Record Period are Independent Third Parties.

Business · 第 189 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-16Application Proof
深圳库博能源股份有限公司Shenzhen Cubenergy Co., Ltd.

前五大供应商采购占比高企且最大供应商为电芯商

According to Frost & Sullivan, this supplier concentration is in line with prevailing industry practice.

Business · 第 135 页

We maintain qualified alternative suppliers for all significant procurement categories, ensuring that the discontinuation of any individual supplier relationship would not materially impact our product development or production operations.

Business · 第 131 页

In 2023, 2024, and 2025, aggregate purchases from our five largest suppliers in each year during the Track Record Period were RMB239.5 million, RMB258.7 million, and RMB371.6 million, accounting for 74.7%, 68.4%, and 61.1% of our total amount of goods purchased, respectively.

Summary · 第 8 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-16Application Proof

前五大供应商采购占比最高达60.2%

Purchases from the five largest suppliers in each year during the Track Record Period amounted to RMB32.2 million, RMB23.9 million and RMB21.5 million in 2023, 2024 and 2025, respectively, accounting for 60.2%, 53.6% and 41.8% of our total purchase amounts for each of the corresponding years, respectively.

Business · 第 143 页

For risks related to the concentration of suppliers, see “Risk Factors — Risks Relating to Our Business and Industry — Our reliance on a limited number of suppliers for certain essential solutions and services could adversely affect our ability to manage our business effectively and subsequently harm our business.”

Business · 第 143 页

Throughout supplier selection and cooperation, we assess suppliers based on qualifications, product reliability, cost optimization potential and market competitiveness, while maintaining diversified sourcing channels to strengthen supply chain resilience.

Business · 第 155 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-15Application Proof

前五大供应商采购占比最高达66.3%,最大供应商占比55.6%

In 2023, 2024 and 2025, purchases from our five largest suppliers accounted for 54.1%, 66.3% and 51.9% of our total purchases, respectively, and purchases from our largest supplier accounted for 35.9%, 55.6% and 46.2% of our total purchases, respectively.

Summary · 第 4 页

As our bargaining power arising from our large volume of purchase and our long-term relationships with such suppliers, we had been able to obtain a sufficient supply of NHPs at reasonable prices and had not experienced any major shortages that materially and adversely affected our operations during the Track Record Period.

Business · 第 161 页

We also entered into framework procurement agreements with certain research animal suppliers during the Track Record Period to ensure a stable supply and procurement price range of the relevant research animals.

Business · 第 163 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-15Application Proof
宁波韵升股份有限公司Ningbo Yunsheng Co., Ltd.

前五大供应商采购占比51%至61%

For the years ended December 31, 2023, 2024 and 2025, purchases from our five largest suppliers for each year during the Track Record Period amounted to RMB2,615.5 million, RMB2,059.2 million, and RMB2,789.3 million respectively, representing 61.0%, 51.0% and 55.1% of our total purchases for the same periods, respectively.

Summary · 第 5 页

Purchases from our largest supplier for each year during the Track Record Period represented 23.5%, 29.3% and 31.6% of our total purchases for the same periods, respectively.

Business · 第 146 页

To mitigate our supplier concentration, we had established business relationships with more than 20 rare earth suppliers as of the Latest Practicable Date.

Business · 第 146 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-15Prospectus
上海仙工智能科技股份有限公司Shanghai Seer Intelligent Technology Co., Ltd.06106.HK

前五大供应商采购占比40.1%、38.7%及32.6%

In 2023, 2024 and 2025, our aggregate purchase from the five largest suppliers in each year during the Track Record Period was RMB50.7 million, RMB71.0 million and RMB75.8 million, respectively, accounting for 40.1%, 38.7% and 32.6% of our total cost of sales, respectively.

Business · 第 163 页

Based on the foregoing, although our top five suppliers for each year during the Track Record Period accounted for a considerable portion of our total cost of sales for the same years, our Directors are of the view that we do not rely on any single supplier.

Business · 第 165 页

Our Directors confirm that we had not experienced any significant material fluctuation in prices set by our suppliers, material breach of contract on the part of our suppliers or delay in delivery of our orders from our suppliers during the Track Record Period.

Business · 第 165 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-15Application Proof
凌科药业(浙江)股份有限公司Lynk Pharmaceuticals Co., Ltd.

API单一来源风险及前五大供应商采购占比35%

To mitigate single-source risk, we develop alternative suppliers early in the process of API procurement and, for other critical intermediates, maintain at least two backup suppliers.

Business · 第 197 页

As such, we did not encounter any material quality problems or receive defective products, nor did we experience any supply shortages that materially and adversely affected our business, financial condition or results of operations during the Track Record Period.

Business · 第 197 页

All of our top five largest suppliers in each year during the Track Record Period were Independent Third Parties.

Business · 第 202 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-15Prospectus
陕西麦科奥特医药科技股份有限公司Shaanxi Micot Pharmaceutical Technology Co., Ltd.02335.HK

五大供应商采购占比39.5%及27.6%

For the years ended December 31, 2024 and 2025, the aggregate purchases attributable to our five largest suppliers in each year during the Track Record Period amounted to RMB31.3 million and RMB26.8 million, respectively, representing 39.5% and 27.6% of our total purchases for the respective periods.

Business · 第 207 页

We believe that we maintain stable relationships with our major suppliers.

Business · 第 207 页

All of our five largest suppliers in each year during the Track Record Period are independent third parties.

Business · 第 209 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-14Application Proof

前五大供应商采购占比14.0%至19.3%

Purchases from our five largest suppliers in each year during the Track Record Period were RMB99.3 million, RMB81.6 million and RMB80.2 million, respectively, representing 19.3%, 14.9% and 14.0% of our total purchases for the same respective years.

Business · 第 116 页

To the best of our knowledge, our five largest suppliers in each year during the Track Record Period were all Independent Third Parties.

Business · 第 119 页

During the Track Record Period and up to the Latest Practicable Date, we did not experience any supply shortages that had a material adverse impact on our business, financial condition, or operating results.

Business · 第 119 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-14Application Proof

往绩记录期间前五大供应商采购占比最高达36.4%

Our purchases from the five largest suppliers in each year during the Track Record Period amounted to RMB16.0 million, RMB48.2 million and RMB78.4 million, representing 30.9%, 36.4% and 23.0% of our total purchases, respectively, and our purchases from the largest supplier in each year during the Track Record Period amounted to RMB5.7 million, RMB13.1 million and RMB20.3 million, representing 11.0%, 9.9% and 5.9% of our total purchases for the same year.

Business · 第 122 页

All of our five largest suppliers were Independent Third Parties, and none of our Directors, their close associates or any of our Shareholders who, to the knowledge of our Directors, owned more than 5% of our issued share capital had any interest in any of our five largest suppliers.

Business · 第 125 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-12Application Proof
烟台蓝纳成生物技术股份有限公司Yantai Lannacheng Biotechnology Co., Ltd.

前五大供应商采购占比最高达68.2%

For the years ended December 31, 2024 and 2025, purchases from our five largest suppliers in each year during the Track Record Period amounted to RMB189.9 million and RMB131.8 million, respectively, representing 68.2% and 54.0% of our total purchases for the respective years; purchases attributable to our single largest supplier, Dongcheng Biochem, our Controlling Shareholder, in each year during the Track Record Period were RMB99.9 million and RMB94.3 million, respectively, accounting for 35.9% and 38.7% of our total purchases for the respective years.

Summary · 第 10 页

For the years ended December 31, 2024 and 2025, purchases from our five largest suppliers in each year during the Track Record Period amounted to RMB189.9 million and RMB131.8 million, representing 68.2% and 54.0% of our total purchases for the respective years.

Business · 第 207 页

To the best of our knowledge, other than Dongcheng Biochem, all of our five largest suppliers for each year during the Track Record Period are independent third parties, and none of our Directors, their respective associates or any shareholder who owned more than 5% of our issued share capital as of the Latest Practicable Date has any interest in any of our five largest suppliers for each year during the Track Record Period.

Business · 第 209 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-12Application Proof
主线科技(北京)股份有限公司Trunk Technology (Beijing) Co., Ltd.

前五大供应商采购占比最高达54.3%

For the years ended December 31, 2023, 2024 and 2025, charges from our five largest suppliers in each year for our key business operations accounted for 39.6%, 54.3% and 43.2% respectively, of our total purchase amount during those periods.

Business · 第 161 页

A substantial portion of our purchase amount of radar, LiDAR and cameras was attributed to limited number of suppliers during the Track Record Period, the main reason being that we have established relatively stable cooperative relationships with these suppliers, and these suppliers are industryleading in terms of price, technology and other aspects.

Business · 第 163 页

We do not rely on any single or limited number of suppliers for our critical components.

Business · 第 161 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-12Application Proof

前五大供应商采购占比高企倚重头部平台

For the years ended December 31, 2023, 2024 and 2025, cost of sales from our five largest suppliers accounted for 99.1%, 88.4% and 95.4% of our total cost of sales, respectively, while our procurement of media resources from our largest supplier for each year of the Track Record Period accounted for 88.7%, 66.6% and 63.3%, respectively.

Summary · 第 5 页

For the years ended December 31, 2023, 2024 and 2025, media costs attributable directly to supplier A and supplier F accounted for 88.7%, 72.3% and 89.2% of our total cost of sales, respectively.

Business · 第 152 页

Our Directors believe that supplier A and supplier F terminating the complementary and mutually beneficial cooperation with us would not only lose China’s cross-border e-commerce industry customers and be detrimental to supplier A and supplier F’s advertising business expansion in China, but is also undesirable from a commercial perspective.

Business · 第 154 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看

Tell us